Case Report: First attempt by off-label use of tenecteplase to treat acute extensive portal venous system thrombosis

Front Cardiovasc Med. 2024 Feb 22:11:1342529. doi: 10.3389/fcvm.2024.1342529. eCollection 2024.

Abstract

Acute extensive portal venous system thrombosis (PVST) can cause lethal complications. Herein, we have for the first time reported the use of anticoagulation combined with systemic thrombolysis by tenecteplase in a male patient with a diagnosis of acute extensive PVST but without liver cirrhosis. After thrombolytic therapy, abdominal pain obviously alleviated. However, urinary bleeding developed, which was reversible by stopping thrombolytic drugs. Finally, this case developed cavernous transformation of the portal vein without portal venous recanalization. In future, the efficacy and safety of tenecteplase should be explored in acute extensive PVST cases.

Keywords: bleeding; case report; portal venous system thrombosis; tenecteplase; thrombolysis.

Publication types

  • Case Reports

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.